To determine how LEF-1 expression might be regulated by Bcr-Abl, we turned to the K562 CML cell line which expresses an imatinib-sensitive form of Bcr-Abl. The gene discussed is LEF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.